LVMC Holdings (KOSE:A900140) agreed to acquire a 49% stake in LD Life Science for KRW 640 million on February 23, 2023. The transaction is expected to close on May 23, 2023. As of May 23, 2023, the transaction is expected to close on September 22, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,610 KRW | -0.57% | -3.33% | +3.37% |
May. 29 | LVMC Holdings Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 21 | LVMC Holdings Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+3.37% | 325M | |
-21.05% | 7.12B | |
+1.56% | 4.09B | |
+8.10% | 1.29B | |
-4.92% | 898M | |
-.--% | 643M | |
-11.72% | 491M | |
-35.15% | 469M | |
-45.89% | 438M | |
-32.14% | 390M |
- Stock Market
- Equities
- A900140 Stock
- News LVMC Holdings
- LVMC Holdings agreed to acquire a 49% stake in LD Life Science for KRW 640 million.